OnCo
ideasIdea

Prizes for unpatentable surgical and radiotherapy techniques proven in trials

Nobody can patent a better way of operating or a shorter radiotherapy schedule, so nobody is rewarded for proving one. Prizes for technique improvements shown to work in trials would fill that gap.

An endowed prize programme paying substantial awards (for example $5 to $20 million shared among the trial team and institutions) for randomised trials that demonstrate a surgical or radiotherapy technique change improving survival, recurrence or major toxicity by a pre-specified margin, with the requirement that the technique is freely described and teachable. Technique innovations such as total mesorectal excision, sentinel node biopsy and hypofractionation have saved more lives and money than most drugs and earned their originators nothing comparable; a prize corrects the reward asymmetry at the margin and attracts talent to technique research.

Hypothesis
Announcing a standing technique prize increases the number of randomised trials of surgical and radiotherapy technique registered per year by at least a third within five years and the number of trainees entering technique-focused research.
Rationale
Prizes reward outputs without requiring exclusivity, exactly the property needed for unpatentable innovations; the Lasker and Breakthrough prizes show that recognition and money shift prestige in science. Surgery and radiotherapy lack an equivalent focused on trial-proven technique.
What would test it
Endow the prize, publish criteria and track technique trial registrations and applicant characteristics over five years against the prior period.
Maturity
speculative
Who has to act
philanthropy
Cost to try
Medium ($1M to $50M)
Years to first evidence
5
Bottlenecks it attacks

Connected

8top

Pages like this

not linked directly; found by shared links